相关实验视频

Updated: Jul 4, 2025

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

纳米医学在瘤中的应用向炎症途径

Fangshun Tan¹, Zhuoying Du¹, Juanjuan Zhong¹

¹College of Basic Medical Science, China Three Gorges University, Yichang 443002, China.

Current medicinal chemistry

|February 9, 2024

概括

纳米技术通过向炎症,为癌症治疗提供了一个有希望的方法. 这篇评论探讨了纳米医学如何利用纳米颗粒来调节癌症治疗的炎症途径.

科学领域:

在瘤学瘤学.
纳米技术纳米技术
免疫学免疫学免疫学

背景情况:

癌症发病率是一个日益严重的全球健康问题.
瘤发生和进展与炎症过程密切相关.
纳米医学正在越来越多地影响癌症的诊断和治疗.

研究的目的:

审查纳米医学在向瘤相关炎症通路中的应用.
阐明纳米颗粒通过炎症影响癌症的机制.
突出纳米粒子作为一种新的癌症治疗策略的潜力.

主要方法:

对纳米医学和癌症治疗当前研究的文献综述.
对研究纳米粒子与瘤炎症途径相互作用的研究进行分析.
对纳米药物的瘤抑制功能的研究结果的综合.

主要成果:

纳米药物通过向炎症途径来证明抑制瘤的能力.
各种纳米颗粒显示出调节瘤微环境的潜力.
在癌症治疗中纳米粒子作用的精确机制正在进行调查.

结论:

纳米粒子代表了癌症治疗的重大进步.
用纳米医学准炎症通路提供了一个有前途的治疗途径.
需要进一步的研究,以充分理解和优化基于纳米粒子的癌症治疗.

关键词:

M1/M2巨细胞. 这是一个巨细胞.纳米医学是一种纳米医学.癌症癌症癌症癌症癌症这是一种炎症炎症炎症炎症.这是一个机制机制.治疗疗法治疗疗法治疗疗法

更多相关视频

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...